• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危乳腺病变:一种预测病理升级和减少不必要手术切除的机器学习模型。

High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.

机构信息

From the Division of Breast Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, 55 Fruit St, WAC 240, Boston, MA 02114 (M.B., C.D.L.); and Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Mass (R.B., A.B.Y., N.J.L., L.Y.).

出版信息

Radiology. 2018 Mar;286(3):810-818. doi: 10.1148/radiol.2017170549. Epub 2017 Oct 17.

DOI:10.1148/radiol.2017170549
PMID:29039725
Abstract

Purpose To develop a machine learning model that allows high-risk breast lesions (HRLs) diagnosed with image-guided needle biopsy that require surgical excision to be distinguished from HRLs that are at low risk for upgrade to cancer at surgery and thus could be surveilled. Materials and Methods Consecutive patients with biopsy-proven HRLs who underwent surgery or at least 2 years of imaging follow-up from June 2006 to April 2015 were identified. A random forest machine learning model was developed to identify HRLs at low risk for upgrade to cancer. Traditional features such as age and HRL histologic results were used in the model, as were text features from the biopsy pathologic report. Results One thousand six HRLs were identified, with a cancer upgrade rate of 11.4% (115 of 1006). A machine learning random forest model was developed with 671 HRLs and tested with an independent set of 335 HRLs. Among the most important traditional features were age and HRL histologic results (eg, atypical ductal hyperplasia). An important text feature from the pathologic reports was "severely atypical." Instead of surgical excision of all HRLs, if those categorized with the model to be at low risk for upgrade were surveilled and the remainder were excised, then 97.4% (37 of 38) of malignancies would have been diagnosed at surgery, and 30.6% (91 of 297) of surgeries of benign lesions could have been avoided. Conclusion This study provides proof of concept that a machine learning model can be applied to predict the risk of upgrade of HRLs to cancer. Use of this model could decrease unnecessary surgery by nearly one-third and could help guide clinical decision making with regard to surveillance versus surgical excision of HRLs. RSNA, 2017.

摘要

目的 开发一种机器学习模型,以区分需要手术切除的经影像引导针活检诊断为高危乳腺病变(HRL)与在手术时升级为癌症风险较低的 HRL,后者可进行监测。

材料与方法 本研究回顾性分析了 2006 年 6 月至 2015 年 4 月期间经活检证实为 HRL 且行手术或至少 2 年影像学随访的连续患者。建立了一个随机森林机器学习模型来识别升级为癌症风险较低的 HRL。该模型使用了传统特征,如年龄和 HRL 组织学结果,以及活检病理报告中的文本特征。

结果 共确定了 1600 例 HRL,癌症升级率为 11.4%(115/1006)。建立了一个机器学习随机森林模型,并用 671 例 HRL 进行训练,并用 335 例 HRL 进行独立测试。最重要的传统特征包括年龄和 HRL 组织学结果(如非典型导管增生)。病理报告中的一个重要文本特征是“严重非典型”。如果将模型归类为升级风险低的所有 HRL 进行监测,而其余 HRL 进行切除,那么 97.4%(37/38)的恶性肿瘤将在手术中诊断,30.6%(91/297)的良性病变手术可以避免。

结论 本研究证明了机器学习模型可用于预测 HRL 升级为癌症的风险。该模型的应用可使不必要的手术减少近三分之一,并有助于指导 HRL 监测与手术切除的临床决策。

相似文献

1
High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision.高危乳腺病变:一种预测病理升级和减少不必要手术切除的机器学习模型。
Radiology. 2018 Mar;286(3):810-818. doi: 10.1148/radiol.2017170549. Epub 2017 Oct 17.
2
High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.MRI 引导核心活检检测到的高危病变:手术切除时的升级率及对管理的影响。
AJR Am J Roentgenol. 2021 Mar;216(3):622-632. doi: 10.2214/AJR.20.23040. Epub 2021 Jan 13.
3
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography.数字二维与断层合成乳腺摄影术对高危乳腺病变的病理升级率。
J Am Coll Surg. 2018 May;226(5):858-867. doi: 10.1016/j.jamcollsurg.2017.12.049. Epub 2018 Feb 2.
4
High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.乳腺 MRI 引导下核心活检诊断的高危病变:升级率及与恶性肿瘤相关的特征。
Breast Cancer Res Treat. 2022 Dec;196(3):517-525. doi: 10.1007/s10549-022-06761-7. Epub 2022 Oct 15.
5
Evaluating the frequency of upgrade to malignancy following surgical excision of high-risk breast lesions and ductal carcinoma in situ identified by core needle biopsy.评估通过核心针活检识别的高危乳腺病变和导管原位癌切除后升级为恶性肿瘤的频率。
Breast J. 2019 Jan;25(1):103-106. doi: 10.1111/tbj.13162. Epub 2018 Nov 20.
6
Breast lesions diagnosed by ultrasound-guided core needle biopsy: Can shearwave elastography predict histologic upgrade after surgery or vaccuum assisted excision?超声引导下粗针穿刺活检诊断的乳腺病变:剪切波弹性成像能否预测手术或真空辅助切除术后的组织学升级?
Clin Imaging. 2018 May-Jun;49:150-155. doi: 10.1016/j.clinimag.2018.03.004. Epub 2018 Mar 3.
7
Minimally Invasive Intact Excision of High-Risk Breast Lesions and Small Breast Cancers: The Intact Percutaneous Excision (IPEX) Registry.微创完整切除高危乳腺病变和小乳腺癌:完整经皮切除术(IPEX)登记。
Ann Surg Oncol. 2019 Apr;26(4):954-960. doi: 10.1245/s10434-019-07212-2. Epub 2019 Feb 12.
8
Prediction of malignancy upgrade rate in high-risk breast lesions using an artificial intelligence model: a retrospective study.利用人工智能模型预测高危乳腺病变的恶性升级率:一项回顾性研究。
Diagn Interv Radiol. 2023 Mar 29;29(2):260-267. doi: 10.5152/dir.2022.211047. Epub 2023 Jan 24.
9
Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions.基于临床和影像学的多变量模型作为决策支持工具的性能,有助于避免高危乳腺病变的不必要手术。
Breast Cancer Res Treat. 2021 Jan;185(2):479-494. doi: 10.1007/s10549-020-05947-1. Epub 2020 Oct 3.
10
The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.使用 INTACT 乳房病变切除系统切除高危和恶性病变的放射学切除。至少进行了 5 年影像学随访的病例系列。
Eur J Surg Oncol. 2014 Jul;40(7):824-9. doi: 10.1016/j.ejso.2014.03.022. Epub 2014 Apr 2.

引用本文的文献

1
Bridging technology and medicine: artificial intelligence in targeted anticancer drug delivery.连接技术与医学:人工智能在靶向抗癌药物递送中的应用
RSC Adv. 2025 Aug 4;15(34):27795-27815. doi: 10.1039/d5ra03747f. eCollection 2025 Aug 1.
2
Artificial Intelligence and Plastic Surgery Resident Education.人工智能与整形外科住院医师教育
Plast Reconstr Surg Glob Open. 2025 Jul 17;13(7):e6924. doi: 10.1097/GOX.0000000000006924. eCollection 2025 Jul.
3
Random forest with preoperative core biopsy categories: a novel method for refining ultrasonic Breast Imaging Reporting and Data System evaluation.
术前粗针活检分类的随机森林算法:一种优化超声乳腺影像报告和数据系统评估的新方法
Quant Imaging Med Surg. 2025 Jun 6;15(6):5362-5372. doi: 10.21037/qims-24-2070. Epub 2025 May 27.
4
Transforming Surgery With Artificial Intelligence: An Early Analysis of Private Industry Trends.用人工智能变革手术:对私营行业趋势的早期分析
Cureus. 2025 Apr 15;17(4):e82328. doi: 10.7759/cureus.82328. eCollection 2025 Apr.
5
Deep learning analysis of hematoxylin and eosin-stained benign breast biopsies to predict future invasive breast cancer.苏木精和伊红染色的良性乳腺活检组织的深度学习分析,以预测未来的浸润性乳腺癌。
JNCI Cancer Spectr. 2025 Apr 30;9(3). doi: 10.1093/jncics/pkaf037.
6
Artificial intelligence in healthcare: transforming patient safety with intelligent systems-A systematic review.医疗保健中的人工智能:利用智能系统转变患者安全——一项系统综述
Front Med (Lausanne). 2025 Jan 8;11:1522554. doi: 10.3389/fmed.2024.1522554. eCollection 2024.
7
Benefits and harms associated with the use of AI-related algorithmic decision-making systems by healthcare professionals: a systematic review.医疗保健专业人员使用与人工智能相关的算法决策系统的益处和危害:一项系统综述。
Lancet Reg Health Eur. 2024 Dec 1;48:101145. doi: 10.1016/j.lanepe.2024.101145. eCollection 2025 Jan.
8
The top 100 most-cited articles on artificial intelligence in breast radiology: a bibliometric analysis.乳腺放射学中人工智能领域被引用次数最多的100篇文章:一项文献计量分析。
Insights Imaging. 2024 Dec 12;15(1):297. doi: 10.1186/s13244-024-01869-4.
9
Assessing the Role of Artificial Intelligence in the Creation of Patient Educational Videos for Corneal Refractive Surgery.评估人工智能在创建角膜屈光手术患者教育视频中的作用。
Cureus. 2024 Oct 14;16(10):e71447. doi: 10.7759/cureus.71447. eCollection 2024 Oct.
10
Is artificial intelligence for medical professionals serving the patients?  : Protocol for a systematic review on patient-relevant benefits and harms of algorithmic decision-making.医学专业人士使用人工智能是为了服务患者吗?:关于算法决策对患者相关获益和危害的系统评价研究方案。
Syst Rev. 2024 Sep 6;13(1):228. doi: 10.1186/s13643-024-02646-6.